Stock Ticker

  • Loading stock data...

TherapeuticsMD Inc (NYSE:TXMD) Provides Additional Information on TX-004HR Regulatory Update

TherapeuticsMD Inc (NYSE:TXMD) has received a letter from the U.S. Food and Drug Administration (FDA) stating the position of the ongoing reviews of the company‚Äôs New Drug Application (NDA) for the TX-004HR. The company expects that FDA will soon conclude their actions on the NDA for TX-004HR which is used to offer treatment in patients […]

Sign Up To Get Our Latest Stocks Alerts